Numerous studies have investigated associations between albumin administration and patient outcomes, including AKI and mortality, under various conditions; however, the results have been inconsistent, with some showing harmful, beneficial, or no effects [5,7,13,14,15,16,17,18,19]. This evidence concerns the gene ALB and acute kidney injury.